Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 3,400 shares at $19.09 ($65K) on 2016-03-29, disclosed to the SEC on 2016-03-31.
Open-market purchase of $65k MRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| MRTX | SELL | 2020-06-16 | $58.2M | — | Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |